Fuanna(002327)2022-04-22 16:00Revenue and Profit - The company's revenue for Q1 2022 was CNY 670,615,258.40, representing a 6.84% increase compared to CNY 627,709,173.65 in the same period last year[4] - Net profit attributable to shareholders was CNY 105,444,005.25, up 13.82% from CNY 92,639,228.63 year-on-year[4] - Total operating revenue for the first quarter was CNY 670,615,258.40, an increase of 6.4% compared to CNY 627,709,173.65 in the previous year[31] - Net profit for the period reached CNY 105,444,005.25, representing a 13.5% increase from CNY 92,639,228.63 in the same quarter last year[36] Cash Flow - The net cash flow from operating activities surged by 751.18%, reaching CNY 27,957,102.58 compared to CNY 3,284,506.45 in the previous year[11] - The net cash flow from operating activities for the current period is ¥27,957,102.58, compared to ¥3,284,506.45 in the previous period, indicating a significant improvement[41] - Cash inflow from operating activities totaled ¥775,893,888.32, slightly down from ¥776,933,484.85 in the previous period[41] - Cash outflow from operating activities decreased to ¥747,936,785.74 from ¥773,648,978.40, reflecting better cost management[41] - The net cash flow from financing activities was negative at ¥1,609,794.30, compared to a larger negative of ¥63,590,882.27 in the previous period[41] Assets and Liabilities - The total assets at the end of the reporting period were CNY 4,670,890,873.55, a decrease of 0.88% from CNY 4,712,551,749.03 at the end of the previous year[4] - The total liabilities decreased to CNY 862,077,625.11 from CNY 1,012,804,189.04, a reduction of 14.9%[30] - The company’s total liabilities decreased by 100% in short-term borrowings, indicating a reduction in reliance on debt financing[7] - The total equity attributable to shareholders of the parent company rose to CNY 3,808,813,248.44, up from CNY 3,699,747,559.99, an increase of 2.9%[30] Expenses - Research and development expenses increased by 64.90% to CNY 8,536,916.96, up from CNY 5,176,890.29 in the previous year[10] - Research and development expenses increased significantly to CNY 22,760,627.24, compared to CNY 13,579,981.21, marking a growth of 67.5%[31] - Total operating costs amounted to CNY 542,969,513.43, up from CNY 519,386,105.75, reflecting a rise of 4.7%[31] Shareholder Information - The total number of common shareholders at the end of the reporting period was 21,702, with the top shareholder holding 37.75% of the shares[17] - The top ten shareholders hold a combined total of 92.73% of the shares, indicating a concentrated ownership structure[17] - The company has not disclosed any related party relationships among the top ten shareholders[20] Other Income and Investments - The company reported a significant increase in other income by 223.05%, amounting to CNY 2,774,757.71 compared to CNY 858,914.03 in the previous year[10] - The company’s investment income rose by 166% to CNY 43,983,985.33, compared to CNY 16,535,604.38 in the previous year[10] Cash and Cash Equivalents - The cash and cash equivalents at the end of the period were CNY 202,766,531.40, down 24.14% from CNY 267,306,730.65 at the end of the previous year[11] - Cash and cash equivalents decreased to ¥217,249,493.40 from ¥422,412,973.66 at the beginning of the year[21] - Cash and cash equivalents at the end of the period amounted to ¥202,766,531.40, compared to ¥267,306,730.65 at the end of the previous period[44]